Studies on the chemotherapy of malaria. I. The treatment of overt falciparum malaria with potentiating combinations of pyrimethamine and sulphormethoxine or dapsone in The Gambia.
D000208:Acute Disease; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003622:Dapsone / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008288:Malaria / Q000188:drug therapy*; D010919:Placebos; D010963:Plasmodium falciparum; D011739:Pyrimethamine / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D010919:Placebos; D013449:Sulfonamides; D003622:Dapsone; D011739:Pyrimethamine